Eikon Therapeutics, Inc. Common Stock (EIKN) vs Rezolute, Inc. (RZLT)

A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$407M
$7.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Rezolute, Inc. logo
RZLT
Rezolute, Inc.
$416M
$4.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EIKN vs RZLT

growth of $100 · dividends reinvested · last 1y
EIKN -49.7% (-49.7%/yr)RZLT +48.8% (+48.8%/yr)RZLT compounded faster over this window
50100150Start $100$50$149
EIKN RZLT

EIKN vs RZLT: by the numbers

  • •RZLT is the larger company ($416M vs $407M market cap).

Metrics side by side

Valuation

MetricEIKNRZLT
P/B ratio0.874.13

Profitability

MetricEIKNRZLT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-69.06%-77.06%
ROIC-46.16%-81.80%

Growth (annualized)

MetricEIKNRZLT
Total return CAGR (5Y)N/A-9.57%

Go deeper

Full EIKN analysisFull RZLT analysisInteractive comparison tool

Dig into the metrics

Eikon Therapeutics, Inc. Common Stock ROERezolute ROEEikon Therapeutics, Inc. Common Stock operating marginRezolute operating marginEikon Therapeutics, Inc. Common Stock revenue growthRezolute revenue growthEikon Therapeutics, Inc. Common Stock free cash flowRezolute free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.